References
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: Implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148
- Waye JS, Chui DHK. The α-globin gene cluster: Genetics and disorders. Clin Invest Med. 2001;24(2):103–109
- Zhou X, Ha SY, Chan GC, et al. Successful mismatched sibling cord blood transplant in Hb Bart’s disease. Bone Marrow Transplant. 2001;28(1):105–107
- Yi JS, Moertel CL, Baker KS. Homozygous α-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr. 2009;154(5):766–768
- Vichinsky E. Advances in the treatment of α-thalassemia. Blood Rev. 2012;26(Suppl 1):S31–S34
- Liang ST, Wong VC, So WW, et al. Homozygous α-thalassaemia: Clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol. 1985;92(7):680–684
- Tan SL, Tseng AM, Thong PW. Bart’s hydrops fetalis-clinical presentation and management-an analysis of 25 cases. Aust NZ J Obstet Gynaecol. 1989;29(3 Pt 1):233–237
- Yang Y, Li DZ. A survey of pregnancies with Hb Bart's disease in Mainland China. Hemoglobin. 2009;33(2):132–136
- Liao C, Mo QH, Li J, et al. Carrier screening for α- and β-thalassemia in pregnancy: The results of an 11-year prospective program in Guangzhou Maternal and Neonatal Hospital. Prenat Diagn. 2005;25(2):163–171
- Kuliev A, Jackson L, Froster U, et al. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, May 21, 1994. Am J Obstet Gynecol. 1996;174(3):807–811
- Brun JL, Mangione R, Gangbo F, et al. Feasibility, accuracy and safety of chorionic villus sampling: A report of 10741 cases. Prenat Diagn. 2003;23(4):295–301
- Liao C, Pan M, Han J, et al. Early prenatal diagnosis of thalassemia: The first report of experience in mainland China. Hemoglobin. 2011;35(4):434–438
- Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol. 2006;108(3):612–616
- Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: A systematic review. Obstet Gynecol. 2007;110(3):687–694
- Odibo AO, Dicke JM, Gray DL, et al. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstet Gynecol. 2008;112(4):813–819
- Tabor A, Vestergaard CH, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis: An 11-year national registry study. Ultrasound Obstet Gynecol. 2009;34(1):19–24
- Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of Hemoglobin Bart disease at midpregnancy. J Ultrasound Med. 2004;23(1):49–55
- Tongsong T, Wanapirak C, Sirivatanapa P, et al. Prenatal eradication of Hb Bart’s hydrops fetalis. J Reprod Med. 2001;46(1):18–22
- Leung KY, Liao C, Li QM, et al. A new strategy for prenatal diagnosis of homozygous α0-thalassemia. Ultrasound Obstet Gynecol. 2006;28(2):173–177
- Lam YH, Tang MH, Lee CP, Tse HY. Prenatal ultrasonographic prediction of homozygous type 1 α-thalassemia at 12 to 13 weeks of gestation. Am J Obstet Gynecol. 1999;180(1):148–150
- Lam YH, Ghosh A, Tang MH, et al. Early ultrasound prediction of pregnancies affected by homozygous α-thalassaemia-1. Prenat Diagn. 1997;17(4):327–332